Similar articles

• Fluoxetine--do the benefits outweigh the risks in adolescent major depression?

  Doggrell SA. Doggrell SA. Expert Opin Pharmacother. 2005 Jan;6(1):147-50. doi: 10.1517/14656566.6.1.147. Expert Opin Pharmacother. 2005. PMID: 15709892 Review.
• Fluoxetine plus cognitive behavioural therapy was most effective for adolescents with major depressive disorder.

  Rew L. Rew L. Evid Based Nurs. 2005 Apr;8(2):45. doi: 10.1136/ebn.8.2.45. Evid Based Nurs. 2005. PMID: 15830418 No abstract available.
• Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.

  Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M. Perlis RH, et al. J Clin Psychopharmacol. 2002 Oct;22(5):474-80. doi: 10.1097/00004714-200210000-00006. J Clin Psychopharmacol. 2002. PMID: 12352270 Clinical Trial.
• Fluoxetine in depressed AUD adolescents: a 1-year follow-up evaluation.

  Cornelius JR, Bukstein OG, Salloum IM, Kelly TM, Wood DS, Clark DB. Cornelius JR, et al. J Child Adolesc Psychopharmacol. 2004 Spring;14(1):33-8. doi: 10.1089/104454604773840463. J Child Adolesc Psychopharmacol. 2004. PMID: 15142389
• Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis.

  Ma D, Zhang Z, Zhang X, Li L. Ma D, et al. Curr Med Res Opin. 2014 Jun;30(6):971-95. doi: 10.1185/03007995.2013.860020. Epub 2014 Feb 28. Curr Med Res Opin. 2014. PMID: 24188102